USP Apparatus 7 Reciprocating Holder Dissolution System

What is the USP Apparatus 7 Reciprocating Holder Dissolution System?

A USP Apparatus 7 system oscillates a sample holder in a small volume of medium, and is designed for transdermal patches, stents and small implants. It is chosen when conventional vessels cannot hold the dosage form.

Overview

Apparatus 7 uses a small volume of medium, typically 10 to 200 mL, held in a vial or cone, and a holder that moves the dosage form up and down at a set rate. Different holder designs accommodate transdermal patches, stents, implants, suppositories and other devices that do not fit a basket or sit properly in a paddle vessel. Stroke length is often about 20 to 30 mm and dip rate commonly 10 to 30 dips per minute, with medium temperature at 32 °C for transdermal systems or 37 °C for implants. The small volume means sink conditions are harder to maintain, so the sample volume, holder position and agitation must be controlled carefully. The apparatus is also used for automatic sequential testing, since the holder can move between rows of vials.

How does it work?

A dissolution system holds a defined volume of dissolution medium at 37 °C and applies controlled agitation to a dosage form. Depending on the apparatus, a basket or paddle rotates in a vessel, a reciprocating cylinder moves the sample up and down between rows of tubes, a flow-through cell pumps medium past a fixed sample, or a holder oscillates in a small volume. Samples are withdrawn at set times by a manual syringe or an automated sampling station, filtered, and the dissolved amount is measured, usually by UV-Vis or HPLC. Results are expressed as percentage dissolved against labelled content, and a profile of several time points shows release behaviour. Temperature, agitation speed, medium composition, degassing and vessel geometry all affect the result, so equipment qualification and method control are critical.

What are the key features?

• Small medium volume in vials or cones
• Reciprocating holder for non-standard forms
• Interchangeable holders for patches and stents
• Stroke length and dip rate programmable
• Medium temperature 32 °C or 37 °C
• Sequential testing across rows of vials

What are the technical specifications?

A typical usp apparatus 7 reciprocating holder dissolution system configuration offers apparatus type of USP Apparatus 7 reciprocating holder, medium volume of 10–200 mL, temperature of 32 °C or 37 °C ±0.5 °C, dip rate of 10–30 dips per minute, stroke length of about 20–30 mm and holder options of Patch, stent, implant, suppository. Values are indicative of the product class; the exact figures for each configuration are confirmed on the quotation and the calibration documents supplied with the instrument.

Which applications is it used for?

The USP Apparatus 7 Reciprocating Holder Dissolution System is used in transdermal patch release testing, drug-eluting stent release, implant and suppository testing and non-standard dosage form release. Across the wider Dissolution Systems class, laboratories also deploy it for immediate-release tablet release testing, modified-release dosage form profiling and bioequivalence support.

Which standards and certifications apply?

Relevant standards and methods include USP <711>, USP <724>, USP <1092>, ICH Q2(R2), IEC 61010-1 and ISO 17025. Certification candidates for this model are CE, IEC 61010-1 compliance and ISO 13485 manufacturing; each is to be confirmed for the specific configuration before shipment, and certificates are supplied only where they have been issued.

Install the system on a stable, level bench away from vibration and draughts, because vibration and air movement disturb flow patterns. Verify vessel temperature at multiple positions inside each vessel, and check rotation speed with a tachometer at defined intervals. Degas medium consistently, since dissolved air changes results, and prepare media accurately with volumetric glassware or calibrated dispensers. Keep vessels clean and free of scratches, use the correct paddle or basket height, and replace worn parts. Document qualification, calibration and every run, including medium composition, degassing method and sample times, because dissolution results are highly method-dependent and subject to regulatory scrutiny.

How do I select the right USP Apparatus 7 Reciprocating Holder Dissolution System?

Choose Apparatus 7 when the dosage form is a patch, stent, implant or suppository that cannot be tested in a basket or paddle vessel. Confirm holder types, medium volume range, dip rate and temperature options, and vial positions. Validate sink conditions carefully because volumes are small.

How does it compare with other Dissolution Systems variants?

Choose the apparatus that the pharmacopoeial monograph or validated in-house method specifies. Paddles and baskets cover most immediate-release tablets and capsules. Reciprocating cylinders suit modified-release dosage forms and automatic media changes. Flow-through cells serve poorly soluble drugs that need large volumes and continuous fresh medium, and reciprocating holders suit transdermal systems, stents and small implants. Then decide on manual or automated sampling, and on UV-Vis or HPLC analysis of the samples. Compare vessel count, temperature control and uniformity, agitation speed accuracy, sampling precision and whether media preparation and cleaning are automated. Confirm qualification documents and software suitable for a GMP environment.